Peter Amenta MD, PhD, is the President and CEO of Joslin Diabetes Center. Before his tenure at Joslin, Dr. Amenta served as a faculty member of Rutgers Robert Wood Johnson Medical School (RWJMS) and University Hospital from 1989 to 2015. In 2006 he was named the Interim Dean of the Medical School and then was appointed Dean in 2008. He stepped down as Dean in 2013 but remained on the faculty until leaving to lead Joslin. He was CEO of the Robert Wood Johnson Medical Group, the school’s faculty medical plan, from 2006 to 2014.
During his twenty-five plus years at RWJMS and University Hospital, Dr. Amenta assumed a number of key administrative roles, including Residency Program Director, Chief of the Pathology Service at Robert Wood Johnson University Hospital, Senior Vice President of Medical Affairs and Chief of Staff, Chair of the Department of Pathology and Laboratory Medicine at the Medical School, the founding Director of the Cancer Institute of New Jersey’s Immunohistochemistry Shared Resource, and member of the Cancer Institute’s Scientific Council and Internal Advisory Board.
During his tenure as Dean, the institution restructured its basic science departmental organization enhancing scientific alignment; established a state-of-the-art electronic health record; restructured and modernized its clinical practice; recruited key faculty to signature clinical and research areas; modernized its medical school curriculum; established interprofessional education programs; contributed to the development of the Child Health Institute of New Jersey; dedicated the Cardiovascular Institute; attained full LCME accreditation; established a program for the national Joining Forces Initiative to aid our military; signed key new affiliation agreements with partner hospitals; established the annual alumni scholarship gala for medical and graduate students; assisted in the expansion of sites for the Chandler Community Health Center, as well as its endowment; and assisted in the transition from the University of Medicine and Dentistry of New Jersey into Rutgers University.
Dr. Amenta is an expert anatomic pathologist, electron microscopist, and immunohistochemist. His studies have contributed to our understanding of novel connective tissue components during development and in normal and pathologic tissue and gastrointestinal disease, the latter being his major clinical interest. He has collaborated with investigators nationally and has contributed to a number of grant-funded projects. He has served as a member of the Board of Trustees of the Joslin Diabetes Center. In addition, he has served on the Editorial Board of Human Pathology and as an invited reviewer for numerous other journals. Finally, he has published more than 150 articles, chapters, and abstracts, including co-editing the textbook Histology-From Normal Microanatomy to Pathology.
Dr. Amenta received his Bachelor of Science degree from Trinity College in Hartford, Connecticut. He completed his medical degree and pathology residency at Hahnemann University in Philadelphia, Pennsylvania, where he also obtained a PhD in Anatomy.